BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26502643)

  • 1. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
    Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
    J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
    Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.
    Bernardi A; Frozza RL; Hoppe JB; Salbego C; Pohlmann AR; Battastini AM; Guterres SS
    Int J Nanomedicine; 2013; 8():711-28. PubMed ID: 23440594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate diethyl ester-loaded lipid-core nanocapsules in aqueous solution increased antineoplastic effects in resistant breast cancer cell line.
    Yurgel VC; Oliveira CP; Begnini KR; Schultze E; Thurow HS; Leon PM; Dellagostin OA; Campos VF; Beck RC; Guterres SS; Collares T; Pohlmann AR; Seixas FK
    Int J Nanomedicine; 2014; 9():1583-91. PubMed ID: 24741306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations.
    Fattahi A; Asgarshamsi M; Hasanzadeh F; Varshosaz J; Rostami M; Mirian M; Sadeghi-aliabadi H
    J Mater Sci Mater Med; 2015 Feb; 26(2):119. PubMed ID: 25677115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.
    Figueiró F; Bernardi A; Frozza RL; Terroso T; Zanotto-Filho A; Jandrey EH; Moreira JC; Salbego CG; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
    J Biomed Nanotechnol; 2013 Mar; 9(3):516-26. PubMed ID: 23621009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
    Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
    Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
    Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
    J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.
    Figueiró F; de Oliveira CP; Bergamin LS; Rockenbach L; Mendes FB; Jandrey EH; Moritz CE; Pettenuzzo LF; Sévigny J; Guterres SS; Pohlmann AR; Battastini AM
    Purinergic Signal; 2016 Jun; 12(2):303-12. PubMed ID: 26910734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive cross-links.
    Abolmaali SS; Tamaddon A; Yousefi G; Javidnia K; Dinarvand R
    Int J Nanomedicine; 2014; 9():2833-48. PubMed ID: 24944513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
    Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
    Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
    Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
    Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(2-Methoxyphenyl)-3-((Piperidin-1-yl)ethyl)thiazolidin-4-One-Loaded Polymeric Nanocapsules: In Vitro Antiglioma Activity and In Vivo Toxicity Evaluation.
    da Silveira EF; Ferreira LM; Gehrcke M; Cruz L; Pedra NS; Ramos PT; Bona NP; Soares MSP; Rodrigues R; Spanevello RM; Cunico W; Stefanello FM; Azambuja JH; Horn AP; Braganhol E
    Cell Mol Neurobiol; 2019 Aug; 39(6):783-797. PubMed ID: 31115733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles.
    Wu P; He X; Wang K; Tan W; He C; Zheng M
    J Biomed Nanotechnol; 2009 Oct; 5(5):557-64. PubMed ID: 20201432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
    Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
    Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor action of diphenyl diselenide nanocapsules: In vitro assessments and preclinical evidence in an animal model of glioblastoma multiforme.
    Ferreira LM; Azambuja JH; da Silveira EF; Marcondes Sari MH; da Cruz Weber Fulco B; Costa Prado V; Gelsleichter NE; Beckenkamp LR; da Cruz Fernandes M; Spanevello RM; Wink MR; de Cassia Sant Anna Alves R; Nogueira CW; Braganhol E; Cruz L
    J Trace Elem Med Biol; 2019 Sep; 55():180-189. PubMed ID: 31345356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.